Archive · 21 Jan 2026
Rallis India Q3 Profit Drops 81.8%
Rallis India, a company that helps farmers, recently shared its financial results for the third quarter of the fiscal year 2026.
The company made much less profit this time compared to last year, only ₹2 crore, which is a big drop of 81.8%.
However, the company sold more products and made more money from its sales, with revenue increasing by 19.3% to ₹623 crore.
The company's profits before tax and other expenses also went up.
Over the past nine months, the company's overall sales and profits have grown.
The company is doing well in selling farm products, seeds, and business-to-business services.
They also launched new products and got patents for their inventions.
The company's leader said they are focusing on selling more products, engaging with customers, and preparing for future seasons.
The company's stock price went down by 4.39% on the day the results were announced.
Rallis India's net profit for Q3 FY26 fell 81.8% to ₹2 crore due to wage code provisions.
Revenue grew 19.3% to ₹623 crore, and EBITDA increased 31.8% to ₹58 crore.
Nine-month revenue rose 9% to ₹2,441 crore, with EBITDA up 18% to ₹362 crore.
Strong volume growth was seen across crop care, seeds, and B2B segments.
The company launched new products and secured patents, focusing on innovation.
- Who
- Rallis India Ltd
- What
- Reported a significant decline in net profit for Q3 FY26
- When
- January 20, 2026
- Where
- India
- Why
- Due to an additional gratuity provision arising from the wage code implementation
Negative Outlook
Positive Outlook
Profit Decline
Negative Outlook
The significant drop in net profit by 81.8% is concerning and indicates financial instability.
Positive Outlook
The profit decline is primarily due to a one-time provision and does not reflect the company's operational performance.
Revenue Growth
Negative Outlook
While revenue has grown, it may not be sufficient to offset the substantial profit decline.
Positive Outlook
The 19.3% increase in revenue and 31.8% rise in EBITDA show strong operational performance and growth potential.
- Net Profit
- ₹2 crore (Q3 FY26)
- Revenue
- ₹623 crore (Q3 FY26)
- EBITDA
- ₹58 crore (Q3 FY26)
- EBITDA Margin
- 9.3% (Q3 FY26)
- PBT (before exceptional items)
- ₹36 crore (Q3 FY26)
- Nine-Month Revenue
- ₹2,441 crore (FY26)
- Nine-Month EBITDA
- ₹362 crore (FY26)
- Nine-Month PAT
- ₹199 crore (FY26)
- Stock Price (BSE)
- ₹229.75 (January 20, 2026)
Sources
Net profit falls 5-fold to ₹2 crore on Wage Code provision - CNBC TV18
Dr Reddy’s expected to post subdued Q3 numbers
Dr Reddy's Labs Q3 Results: Profit dips 14% YoY to ₹1210 crore; revenue grows 4%
Dr Reddy’s Laboratories Q3 results: Net profit slips 15% to ₹1,189 cr
Broker’s call: Cyient DLM (Buy)